Mechanism of xihuang pill inhibition of SLC7A11 deubiquitination through downregulation of the Otub1 to promote ferroptosis in triple-negative breast cancer
Bibliographic Data
| ID | 14738366 |
|---|---|
| Authors | Yebei Qiu (Jinan University), Guijuan Zhang (0000-0002-9545-8668, Jinan University), Ran Su (Jinan University), Yiliu Chen (0000-0003-0309-1510, Jinan University), Chu Yi (Jinan University), Sha Zhan (Jinan University), Haotian Zhang (0009-0008-1415-6221, Jinan University), Tianyang Liu (0000-0002-5462-5714), Jialin Li (0000-0002-1787-4236, First Affiliated Hospital of Jinan University), Yangjie Wu (0000-0002-0134-0870, First Affiliated Hospital of Jinan University), Xianxin Yan (Jinan University, corresponding author), Min Ma (0000-0002-6652-7214, Jinan University, corresponding author), Ma Min (0000-0001-5236-1295) |
| Year | 2025 |
| Volume | 353 |
| Issue | Pt B |
| Pages | 120456 |
| Publication date | 2025-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2025.120456 |
| PMID | 40846041 |
| OpenAlex | W4413407350 |
| Language | EN |
| Citations received | 1 |
| References cited | 62 |
Breast cancer · Cancer · Downregulation and upregulation · Mechanism (biology · Pill · Traditional medicine · Triple-negative breast cancer · Cancer, Lipids, and Metabolism · Chemistry · Ferroptosis and cancer prognosis · Medicine · Philosophy · RNA modifications and cancer · Biochemistry · Internal Medicine · Pharmacology
Ferroptosis
Ferroptosis
Global Cancer Statistics 2020
The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer
Xihuang pill suppressed primary liver cancer growth by downregulation of AFP and YAP signaling
The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Xihuang pill suppresses breast cancer malignancy by inhibiting TGF-β signaling and acquires chemotherapy benefits
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2026 - 2026 (1) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 1 |